CLEC10A and lung carcinoma: Obviously, more research is needed to understand the role of HERV-K (HML-2) in human lung cancer and to clarify its role in the pathogenesis of the disease, which may provide new ideas for the further discovery of tumor-associated antigens and the development of new treatments for lung cancer.